{"version":"1.0","provider_name":"Policy Options","provider_url":"https:\/\/policyoptions.irpp.org\/fr\/","title":"Good governance and decision-making on drug coverage","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"w17unjcT6X\"><a href=\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/\">Good governance and decision-making on drug coverage<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/policyoptions.irpp.org\/fr\/2018\/01\/good-governance-and-decision-making-on-drug-coverage\/embed\/#?secret=w17unjcT6X\" width=\"600\" height=\"338\" title=\"&#8220;Good governance and decision-making on drug coverage&#8221; &#8212; Policy Options\" data-secret=\"w17unjcT6X\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/policyoptions.irpp.org\/wp-content\/uploads\/2025\/08\/Final-option-3-rawson-money-no-us.jpg","thumbnail_width":2000,"thumbnail_height":700,"description":"The federal Minister of Health has initiated an external\u00a0review\u00a0of eight pan-Canadian health organizations. One of these is\u00a0the\u00a0Canadian Agency for Drugs and Technologies in Health (CADTH), which evaluates\u00a0and recommends\u00a0new drugs for insurance coverage within all federal, provincial and territorial public drug plans, except those in Quebec. CADTH\u00a0describes\u00a0itself as \u201can independent, not-for-profit organization responsible for providing Canada\u2019s [&hellip;]"}